PACC1 and colorectal cancer: Consistent with our present data, Zhao et al. found that knockdown or upregulation silencing of TMEM206 inhibited or promoted the proliferation of colorectal cancer cells [21], which supports our hypothesis that TMEM206 is an oncogenic gene and may be a promising therapeutic target.